Sky Labs announced that it is supporting the Established Investigator Award for Clinical Hypertension, developed by the American Heart Association (the Association).

This support follows a Memorandum of Understanding (MoU) signed with the Association last September. It is expected to significantly support the advancement of hypertension research globally.

Sky Labs will provide support for the Established Investigator Award for Clinical Hypertension, which will provide funding to a total of three outstanding researchers who have achieved exceptional research accomplishments in the field of hypertension from 2026 to 2028.

During this period, Sky Labs will provide approximately $90,000 in total funding to the Association. This amount includes the annual honorariums for the selected investigators as well as all program-related costs required to support the operation of the awards.

Eligibility requires membership in the Association’s Scientific Council on Hypertension.

Jack Byunghwan Lee, CEO of Sky Labs, stated, “We are deeply honoured to look forward to and contribute to world-class hypertension research outcomes through our support for the American Heart Association. We will intensify clinical research to validate the effectiveness of blood pressure management solutions while also dedicating efforts to research and development to support these initiatives.”

Sky Labs is an AI healthcare company providing innovative chronic disease management solutions through ‘CART,’ the world’s first medical-grade ring-type wearable blood pressure monitor.